May 29 (SeeNews) - Bulgarian blue-chip drug maker Sopharma posted a 29% year-on-year rise in its first-quarter consolidated net profit to 9.7 million levs ($7.0 million/4.9 million euro) as revenues grew by 8.0% on the back of robust domestic sales.